Local heterogeneity in Lassa fever serology in rural Nigeria: Implications for vaccine trial site selection
PLOS Neglected Tropical Diseases · 2026
DOI: 10.1371/journal.pntd.0014379 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2026. Verfasst von David Simons und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anthropology, Pennsylvania State University, State College, Pennsylvania, United States of America. Hauptthemen laut MEDLINE: Lassa Fever, Antibodies, Viral, Lassa virus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health‐National Institutes of Food and Agriculture Ecology and Evolution of Infectious Disease Award, Biotechnology and Biological Sciences Research Council, NSF‐NIH‐NIFA Ecology and Evolution of Infectious Disease Award.
Abstract (Originalsprache)
Introduction
Lassa virus (LASV) causes significant morbidity in West Africa, yet vaccine trial planning is hampered by a lack of high-resolution, community-level seroprevalence data. We aimed to characterize the fine-scale spatial and demographic heterogeneity of LASV exposure in rural Nigeria to inform site selection strategies.
Methods
We conducted a cross-sectional serosurvey across nine villages in three Nigerian states (Benue, Ebonyi, and Cross River). We recruited 1,874 individuals and tested for LASV IgG using the highly specific Panadea LASV IgG ELISA. We employed Bayesian hierarchical models to estimate seroprevalence and investigated 21 pre-specified demographic, environmental, and behavioral risk factors for association with seropositivity. Village-specific transmission dynamics were explored using Bayesian generalized additive models for age-stratified seroprevalence.
Results
The overall model-based IgG seroprevalence was 3.2% (95% CrI: 2.5–4.0%). We observed marked fine-scale heterogeneity, with village-level estimates ranging from 0.8% to 6.5%. Age-seroprevalence curves suggested? divergent transmission dynamics, ranging from cumulative endemic exposure to recent focal outbreaks in younger cohorts. Likely constrained by low overall prevalence and high exposure ubiquity, univariable analyses detected no strong or consistent associations between seropositivity and the 21 pre-specified risk factors, including rodent consumption and agricultural practices. No significant village-wide spatial clustering of seropositive households was observed via Local Getis-Ord (Gi*).
Discussion
LASV exposure in rural Nigeria is characterized by low overall prevalence punctuated by significant hyper-local variation. The lack of consistent individual-level risk factors and the divergent age-exposure profiles suggest that risk may be influenced by stochastic, localized ecological drivers or obscured by the temporal misalignment of cross-sectional surveys. Vaccine trial site selection must move beyond regional incidence data to incorporate interdisciplinary, One Health metrics including high-resolution human serosurveillance and longitudinal reservoir monitoring to identify active transmission hotspots.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Anthropology, Pennsylvania State University, State College, Pennsylvania, United States of America.
- Science Department, Natural History Museum, London, United Kingdom.
- Calabar Institute for Tropical Disease Research and Prevention, University of Calabar, Calabar, Cross River, Nigeria.
- Nigeria Centre for Disease Control, Abuja, Nigeria.
- Celia Scott Weatherhead School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana, United States of America.
ORCID-Profile: David Simons
Förderung
- National Institutes of Health‐National Institutes of Food and Agriculture Ecology and Evolution of Infectious Disease Award
- Biotechnology and Biological Sciences Research Council
- NSF‐NIH‐NIFA Ecology and Evolution of Infectious Disease Award
- BBSRC
Zitieren
APA
Simons, D., Harden, C., Imirzian, N., Thompson, K. E. T., Ifebueme, N. M., Eziechina, S., Ignatius, H., Marcus, D., Aderibigbe, F., Koninga, J. T., Meremikwu, M., Moses, L., Redding, D. W., & Friant, S. (2026). Local heterogeneity in Lassa fever serology in rural Nigeria: Implications for vaccine trial site selection. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0014379
Vancouver
Simons D, Harden C, Imirzian N, Thompson KET, Ifebueme NM, Eziechina S, et al. Local heterogeneity in Lassa fever serology in rural Nigeria: Implications for vaccine trial site selection. PLOS Neglected Tropical Diseases. 2026. doi:10.1371/journal.pntd.0014379
BibTeX
@article{Simons2026,
author = {Simons, David and Harden, Christina and Imirzian, Natalie and Thompson, Katharine E T and Ifebueme, Nzube Michael and Eziechina, Sunday and Ignatius, Helen and Marcus, Diana and Aderibigbe, Fisayomi and Koninga, James T and Meremikwu, Martin and Moses, Lina and Redding, David W and Friant, Sagan},
title = {Local heterogeneity in Lassa fever serology in rural Nigeria: Implications for vaccine trial site selection},
journal = {PLOS Neglected Tropical Diseases},
year = {2026},
doi = {10.1371/journal.pntd.0014379}
}
EUVIMED